BSJ-04-132 is a selective PROTAC that links Cereblon and CDK ligands, effectively targeting CDK4 for degradation. Based on Ribociclib, it specifically degrades CDK4 without affecting CDK6 or IKZF1/3, highlighting its focused mechanism of action while contributing to research on CDK-related pathways.
Usually ships within 24 hours.